Drug improves health in obese patients on a diet

03/16/2010 | Medscape (free registration)

Australian scientists report that obese patients who were placed on a low-calorie diet and took ezetimibe had reduced inflammation, hepatic steatosis and cardiovascular risk factors. A study of 25 obese patients found those who received ezetimibe showed lower levels of triglycerides, LDL cholesterol and other markers after four months compared with those who dieted only.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ